Biodelivery Sciences International


Biotech Beat: Roth Capital Analysts Weigh In on Galena Biopharma Inc (GALE) and BioDelivery Sciences International, Inc. (BDSI)

Roth Capital analysts weigh in on the small-cap biotech company Galena Biopharma Inc (NASDAQ:GALE) and drug delivery company BioDelivery Sciences International, Inc. (NASDAQ:BDSI) after both companies …

Roth Capital Cuts Biodelivery Price Target To Reflect More Conservative Bunavail Launch Assumptions

In a research report published Friday, Roth Capital analyst Scott Henry upgraded shares of Biodelivery Sciences (NASDAQ:BDSI) from Hold to Buy rating, but reduced his …

William Blair Reiterates Outperform On Biodelivery Sciences Following Management Meetings With investors

In a research report published today, William Blair analyst Tim Lugo reiterated an Outperform rating on Biodelivery Sciences (NASDAQ:BDSI) with a $25 price …

Biodelivery: We Remain On The Sidelines Pending A Few More Weeks Of Bunavail Prescriptions, Say Roth Capital

Roth Capital analyst Scott Henry maintained a Neutral rating on Biodelivery Sciences (NASDAQ:BDSI) with a $20 price target, which represents a potential upside …

William Blair Remains Bullish On BioDelivery Following Launch Update

In a research report issued Wednesday, William Blair analyst Tim Lugo maintained an Outperform rating on BioDelivery Sciences International (NASDAQ:BDSI) with a $25 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts